Viewing StudyNCT00014287



Ignite Creation Date: 2024-05-05 @ 11:23 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00014287
Status: WITHDRAWN
Last Update Posted: 2013-12-19
First Post: 2001-04-10

Brief Title: Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer
Sponsor: University of Pittsburgh
Organization: University of Pittsburgh

Conditions & Keywords Data

Conditions:
Name
Bladder Cancer
Keywords:
Name View
recurrent bladder cancer View
stage 0 bladder cancer View
stage I bladder cancer View